Search
Close this search box.
Register
Healthed-White-on-Blue
Search
Close this search box.
Richmond, Prof Peter_V2

Prof Peter Richmond

Consultant Paediatric Immunologist & Paediatrician; Perth Children’s Hospital; Head of the Vaccine Trials Group, Wesfarmers Centre of Vaccines and Infectious Diseases
Peter is a general paediatrician and paediatric immunologist who is currently Head of the Department of Immunology at Perth Children’s Hospital and Professor of Paediatrics at the University of Western Australia. He leads the Vaccine Trials Group at Telethon Kids Institute who undertake clinical trials, epidemiological and laboratory research in infectious disease with the aim of improving the health of the population locally, nationally and globally.

More from this expert

Peter Richmond_Bexsero_22min.00_00_05_23.Still005
Videos iconVideos

Real-world evidence for meningococcal B vaccines and how to have MenB conversations in general practice

In this Product Explainer, Paediatrician and Paediatric Immunologist Prof Peter Richmond explains how Meningococcal serogroup B (MenB) disease remains the most common cause of IMD in children, adolescents and young adults, and provides an overview of the real-world evidence for MenB vaccines, and conversation strategies for use with families in general practice (6 mins).

MicrosoftTeams-image (36)1
Podcasts iconPodcasts

RSV – Past, present & future

RSV is a very important cause of disease for young children and older adults in winter season (May – September). Understand the natural course of the disease, and advice to give parents.

doctor-563428_640

Meningitis prevention – Conversation strategies

Conversation strategies to educate patients so that they can make a realistic assessment of the cost benefit equation.

By Prof Peter Richmond
Podcasts iconPodcasts
Peter Richmond_Bexsero_22min.00_00_05_23.Still005

Conversations on meningococcal disease with parents

In this Product Explainer, Paediatrician and Paediatric Immunologist A/Prof Peter Richmond explains which patients are most at risk for meningococcal B, the risk reduction benefits of meningococcal B vaccination and why it is important to have conversations with parents in which the risk/benefits of vaccination are clearly explained (5 mins).

By Prof Peter Richmond
Videos iconVideos
Peter Richmond_Bexsero_22min.00_00_05_23.Still005

Real-world evidence for meningococcal B vaccines and how to have MenB conversations in general practice

In this Product Explainer, Paediatrician and Paediatric Immunologist Prof Peter Richmond explains how Meningococcal serogroup B (MenB) disease remains the most common cause of IMD in children, adolescents and young adults, and provides an overview of the real-world evidence for MenB vaccines, and conversation strategies for use with families in general practice (6 mins).

By Prof Peter Richmond
Videos iconVideos
shutterstock_2083417909

Meningitis in adolescents: Health risks associated with social behaviours

The incidence of meningitis in adolescents and young people

By Prof Peter Richmond
Podcasts iconPodcasts
MicrosoftTeams-image (36)1

RSV – Past, present & future

RSV is a very important cause of disease for young children and older adults in winter season (May – September). Understand the natural course of the disease, and advice to give parents.

By Prof Peter Richmond
Podcasts iconPodcasts

Education by clinicians, for clinicians

Get the app

Site

Company

Connect

Legal

Discover

Healthed

CPD platform